glp-1 based therapeutics summit I'm in Philadelphia this week giving a talk on the treatment class and quantitative imaging GLP-1 Summit 2025

Alpha-Arbutin Targets dark spots safely

15 Payers are currently reeling from the financial impact of GLP-1 prescriptions

Vision Loss and NAION Concerns Non-arteritic anterior ischemic optic neuropathy (NAION) has emerged as a particularly devastating injury linked to GLP-1 medications, representing the second leading cause of optic nerve-related blindness in adults

For areas with noticeable roughness or keratin buildup, layer once more and massage gently

These findings support their role as a cornerstone therapy in the management of heart failure across the entire clinical spectrum ( Table 1 )

Signs you are escalating too fast Watch for these indicators that your dose is advancing too quickly for your postpartum body: Persistent nausea lasting more than three days after a dose increase Inability to consume at least 1,500 calories daily (1,800 or more if breastfeeding) Noticeable drop in breast milk supply Fatigue significantly worse than your postpartum baseline Weight loss exceeding three pounds per week consistently Dizziness or lightheadedness, especially when standing If any of these occur, the standard recommendation is to hold at your current dose for an additional four weeks before attempting another increase